Pharmaceutical Executive September 3, 2024
As the second half of 2024 begins, an industry expert discusses how mergers and acquisitions are trending in the pharma industry.
After a post-pandemic slow down, the pharma industry saw a return of mergers and acquisitions (M&A) late last year and early this year. Cheryl Reicin, international chair of life sciences at Mintz, spoke with Pharmaceutical Executive about the current trends in the industry.
Pharmaceutical Executive: What’s sparked the recent surge in M&A in the life sciences industry?
Cheryl Reicin: Historically, in this industry, when the capital markets and venture capital are tight, as they have been in the last two years, companies need to look at earlier M&A and licensing deals (which are often precursors to M&A deals in this...
Today's Sponsors
Today's Sponsor